Related Experiment Video
Updated: Sep 16, 2025
11:35
Decellularization and Recellularization Methodology for Human Saphenous Veins
Published on: July 27, 2018
14.4K
Growth hormone suppression in endothelial dysfunction
1School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA, USA.
Cell Cycle (Georgetown, Tex.)
|July 12, 2025
Summary
Growth Hormone-Releasing Hormone and Somatostatin regulate Growth Hormone (GH) secretion. This study explores the therapeutic potential of suppressing GH to treat endothelium-dependent disorders.
Area of Science:
- Endocrinology
- Vascular Biology
Background:
- Growth Hormone (GH) secretion is tightly regulated by opposing hormones: Growth Hormone-Releasing Hormone (GHRH) and Somatostatin.
- Endothelium-dependent disorders represent a significant clinical challenge, impacting vascular health.
Purpose of the Study:
- To investigate the potential therapeutic benefits of inhibiting Growth Hormone (GH) secretion.
- To explore the role of GH suppression in managing endothelium-dependent disorders.
Main Methods:
- Review of recent findings on GH regulation.
- Analysis of the interplay between GH and endothelial function.
Main Results:
- GHRH and Somatostatin exhibit opposing effects on GH release.
- Emerging evidence suggests a link between GH levels and endothelial dysfunction.
Conclusions:
- GH suppression may offer a novel therapeutic strategy for endothelium-dependent disorders.
- Further research is warranted to elucidate the mechanisms and clinical efficacy.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
01:15Hypoglycemia and Glucagon
342
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
342
01:27Major Hormones and Their Functions
810
Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
810
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
226
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
226
01:16Hormones Regulating Blood Glucose
4.1K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
4.1K
01:22Target Cell Response to Hormones
3.6K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
3.6K